https://jbmtct.com.br/seer/index.php/jbmtct/gateway/plugin/AnnouncementFeedGatewayPlugin/atomJOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY: Announcements2020-05-25T13:01:54+00:00Open Journal Systems<p>The JBMTCT is an official electronic scientific publication of the Brazilian Society of Bone Marrow Transplantation (SBTMO), created in 2020, edited every three months and in compliance with a defined editorial policy.</p> <p>Publishes letter to the editor, unpublished articles, review articles, short communication, opinion articles, case reports, conduct protocols and research articles in progress / completed with the aim of spreading knowledge and innovative research in medicine fields, bone marrow transplantation, cell therapy and related sciences.</p> <p>Target audience: this journal is aimed to researchers, teachers, professionals and students with an interest in the medicine field (bone marrow transplantation and cell therapy) and related sciences.<br /><br />Periodicity of the jornal:<br />Quarterly</p>https://jbmtct.com.br/seer/index.php/jbmtct/announcement/view/1Latest News: First Edition - Vol. 1, n.1 (2020)2020-05-25T13:01:54+00:00JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY<p><img src="https://jbmtct.ojsbr.com/public/site/images/limaocravo/caparevista1.jpg" /></p> <p>One of the review articles is the Analysis of Expansion Mesenchymal Stromal in Patients with low risk myelodysplastic Syndrome.</p> <p>The study aims to evaluate the expansion of mesenchymal stromal cells (MSCs) and the expression of p53 protein in patients with SMD, low risk, according to the International Prognostic System (IPSS), in order to demonstrate the importance of these evaluations also diagnostics.</p> <p><a title="Vol1,n1" href="https://jbmtct.ojsbr.com/index.php/jbmtct/issue/view/1" target="_blank" rel="noopener">Click here and access this edition.</a></p>2020-05-25T13:01:54+00:00